NICE guidance (NG28) emphasises that GLP-1 receptor agonists should be prescribed alongside dietary modification and increased physical activity
Research Protocol Considerations for Retatrutide For researchers studying retatrutide in preclinical or in vitro models, understanding the compounds physicochemical properties is essential to experimental design
This was a well-conducted study that adds to the rather confused literature on the effects of these widely used drugs on the risk for cancer
Changes in menstrual bleeding can signal other health conditions, including fibroids, ovulation issues, hypothyroidism, polyendocrine metabolic ovarian syndrome (formerly PCOS), endometriosis, pelvic inflammatory disease (PID), bleeding disorders, and endometrial cancer
Retatrutide includes glucagon receptor activity, and research teams monitor cardiovascular measures during studies